Healthcare provider cost of antimicrobial resistance in two teaching hospitals in Ghana.

ABSTRACT: Understanding the healthcare provider costs of antimicrobial resistance (AMR) in lower-middle-income countries would motivate healthcare facilities to prioritize reducing the AMR burden. This study evaluates the extra length of stay and the associated healthcare provider costs due to AMR to estimate the potential economic benefits of AMR prevention strategies. We combined data from a parallel cohort study with administrative data from the participating hospitals. The parallel cohort study prospectively matched a cohort of patients with bloodstream infections caused by third-generation cephalosporin-resistant enterobacteria and methicillin-resistant Staphylococcus aureus (AMR cohort) with two control arms: patients infected with similar susceptible bacteria and a cohort of uninfected contro

SUBMITTER: Otieku E 

PROVIDER: S-EPMC11020270 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature